Prevalence of gastro-intestinal symptoms among COVID-19 patients and the association with disease clinical outcomes

AIM: This study examined the various manifestations of COVID-19 in people's gastro-intestinal system and how gastro-intestinal involvement relates to the progression and outcome of the disease. METHODOLOGY: A questionnaire survey was used to collect data from 561 COVID-19 patients between Febru...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Momani, Hafez, Aolymat, Iman, Almasri, Muna, Mahmoud, Sameer Alhaj, Mashal, Safaa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Science Ltd 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167716/
https://www.ncbi.nlm.nih.gov/pubmed/37180610
http://dx.doi.org/10.2144/fsoa-2023-0040
Descripción
Sumario:AIM: This study examined the various manifestations of COVID-19 in people's gastro-intestinal system and how gastro-intestinal involvement relates to the progression and outcome of the disease. METHODOLOGY: A questionnaire survey was used to collect data from 561 COVID-19 patients between February 6 and 6 April 2022. Laboratory data and clinical outcomes were obtained from the patients' medical records. RESULTS: 39.9% of patients presented gastro-intestinal symptoms, mainly loss of appetite, nausea, vomiting and diarrhea. Gastro-intestinal symptoms were not linked to poorer outcomes such as mortality, ICU admission or length of hospital stays. CONCLUSION: gastro-intestinal symptoms were common among patients and may manifest with respiratory symptoms. We recommended clinicians to watch out for gastro-intestinal symptoms as related to COVID-19 infection.

Ejemplares similares